Trials / Completed
CompletedNCT00496236
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer
A Phase I/II Safety, Tolerability and "Proof of Concept" Study of Radiotherapy, Cetuximab, and Intratumoral Injections of TNFerade™ Biologic (AdGVEGR.TNF.11D) for Elderly or Frail Patients or Intermediate Stage Patients With Head and Neck Cancer
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- GenVec · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is looking at the safety and tolerability of TNFeradeä Biologic combined with conventional once daily radiation therapy in elderly or frail patients with new onset locally advanced head and neck tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TNFerade biologic |
Timeline
- First posted
- 2007-07-04
- Last updated
- 2012-02-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00496236. Inclusion in this directory is not an endorsement.